Results 201 to 210 of about 74,387 (246)
Some of the next articles are maybe not open access.
Journal of Cardiovascular Pharmacology, 1990
Because all antibodies to bradykinin described to date more or less cross-react with larger and smaller bradykinin derivatives, the aim of the present study was the induction of a specific antibody against bradykinin. A bradykinin derivative, containing a Cys residue at position 6 instead of Ser, was linked to BSA by using a new heterobifunctional ...
U, Hilgenfeldt, R, Linke, W, König
openaire +2 more sources
Because all antibodies to bradykinin described to date more or less cross-react with larger and smaller bradykinin derivatives, the aim of the present study was the induction of a specific antibody against bradykinin. A bradykinin derivative, containing a Cys residue at position 6 instead of Ser, was linked to BSA by using a new heterobifunctional ...
U, Hilgenfeldt, R, Linke, W, König
openaire +2 more sources
Radioimmunoassay of Bradykinin
Nature, 1967IN the past few years highly sensitive and specific radioimmunological methods have been developed for the determination of many polypeptide hormones1. Radioimmunoassays are usually based on the competitive reaction of a measured amount of polypeptide hormone labelled with iodine-125 and iodine-131 and varying amounts of unlabelled hormone with hormone
H, Rinderknecht +2 more
openaire +2 more sources
Experientia, 1962
Incubates of the venom ofCrotalus atrox resp. Padutin-Bayer (Kallikrein) with globulines from ox plasma were bioassayed on theileum of guineapigs, theduodenum of rats and theblood-pressure of rabbits and compared with the effects of synthetic bradykinin.
P, HOLTZ, B, HEICKE, S, BARCK
openaire +2 more sources
Incubates of the venom ofCrotalus atrox resp. Padutin-Bayer (Kallikrein) with globulines from ox plasma were bioassayed on theileum of guineapigs, theduodenum of rats and theblood-pressure of rabbits and compared with the effects of synthetic bradykinin.
P, HOLTZ, B, HEICKE, S, BARCK
openaire +2 more sources
Bradykinin Potentiating Factor
Chest, 1971The bradykinin-potentiating factor (BPF) is a component of Bothrops jararaca venom which potentiates in vitro as well as in vivo some pharmacological effects of bradykinin (Ferreira, 1964; 1965). This communication deals with its purification, biochemical characteristics, pharmacological actions,and some considerations of the mechanism of bradykinin ...
L J, Greene, S H, Ferreira, J M, Stewart
openaire +2 more sources
2014
Diseases which have been demonstrated to be caused by increased plasma levels of bradykinin all have angioedema as the common major clinical manifestation. Angioedema due to therapy with angiotensin-converting enzyme (ACE) inhibitors is caused by suppressed bradykinin degradation so that it accumulates. This occurs because ACE metabolizes bradykinin by
openaire +2 more sources
Diseases which have been demonstrated to be caused by increased plasma levels of bradykinin all have angioedema as the common major clinical manifestation. Angioedema due to therapy with angiotensin-converting enzyme (ACE) inhibitors is caused by suppressed bradykinin degradation so that it accumulates. This occurs because ACE metabolizes bradykinin by
openaire +2 more sources